Structure

InChI Key JOFWLTCLBGQGBO-UHFFFAOYSA-N
Smile Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
InChI
InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H12Cl2N4
Molecular Weight 343.22
AlogP 4.23
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 1.0
Polar Surface Area 43.07
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 23.0

Pharmacology

Action Mechanism of Action Reference
POSITIVE ALLOSTERIC MODULATOR GABA-A receptor; anion channel positive allosteric modulator FDA ISBN
Primary Target
GABAA receptor α1 subunit
GABAA receptor α2 subunit
GABAA receptor α3 subunit
GABAA receptor α5 subunit

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Schizophrenia 3 D012559 ClinicalTrials
Anxiety 3 D001007 ClinicalTrials
Dementia 3 D003704 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials
Substance-Related Disorders 2 D019966 ClinicalTrials

Related Entries

MCS

Scaffolds

Side Effects from Label

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
24.92
Nervous system disorders
20.38
General disorders and administration site conditions
13.6
Injury, poisoning and procedural complications
12.46
Vascular disorders
3.52
Cardiac disorders
3.3
Gastrointestinal disorders
2.97
Respiratory, thoracic and mediastinal disorders
2.61
Immune system disorders
2.36
Investigations
2.2

Cross References

Resources Reference
CAS NUMBER 28911-01-5
ChEBI 9674
ChEMBL CHEMBL646
DrugBank DB00897
DrugCentral 2729
EPA CompTox DTXSID6046763
FDA SRS 1HM943223R
Human Metabolome Database HMDB0015034
Guide to Pharmacology 7313
KEGG D00387
PharmGKB PA451753
PubChem 5556
SureChEMBL SCHEMBL29228
ZINC ZINC000000002212